Is Alcon Inc. (ALC) a Buy, Sell, or Hold?
Alcon Inc.
NYSE:ALC
$68.48 USD
$1.62 (2.42%)
- Volume
- 2.08M
- Average Volume
- 2.11M
- Market Capitalization
- $33.4B
- P/E Ratio
- 41.25
- Dividend Yield
- 0.52%
- Price Target
- $80.00
- Year High
- $92.55
- Year Low
- $61.84
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.20
- Current Ratio
- $2.20
Industry, Sector & symbol
| Stock Exchange | NYSE |
| CEO | David J. Endicott |
| Industry | Medical - Specialties |
| Sector | Healthcare |
| Current Symbol | ALC |
| CUSIP | H01301128 |
| CIK | 0001167379 |
| Web | https://www.alcon.com |
| Phone | 41 58 911 20 00 |
| Currency | USD |
| Employees | 25628 |
| Country | CH |
Liquidity
| Debt-to-Equity Ratio | 0.24 |
| Payout Ratio | 0.20 |
| Current Ratio | 2.20 |
| Quick Ratio | 1.39 |
| Cash Ratio | 0.53 |
Sales & Book Value
| Annual Sales | $10.4B |
| Price / Sales | 3.16 |
| Cash Flow | 3.37 |
| Price / Cash Flow | 20.35 |
| Price / Book | 1.50 |
Price Target and Rating
| Average Stock Price Forecast | $80.00 |
| High Stock Price Forecast | $97.00 |
| Low Stock Price Forecast | $70.00 |
| Forecast Upside/Downside | -14.40% |
| Consensus Rating | Neutral |
| Rating Score(0-5) | 3 |
| Research Coverage | 26 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $1.98 |
| Trailing P/E Ratio | 41.25 |
| PEG Ratio | -1.55 |
| P/E Growth | -1.55 |
| Net Income | $980M |
| Net Margin | 7.71% |
| Pretax Margin | 9.27% |
| Return on Equity | 3.69% |
| Return on Assets | 2.56% |
Financials Score
| AltmanZ Score | 2.69 |
| Piotroski Score | 8.00 |
| Working Capital | 3.64B |
| Total Assets | 31.79B |
| Ebit | 1.13B |
| Market Cap | 33.42B |
| Total Liabilities | 9.54B |
Poll Results
About Alcon Inc. (NYSE:ALC) Stock
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Pre ... sbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Why Alcon (ALC) is a Top Value Stock for the Long-Term
2026-07-14 10:40:33
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Buy 3 AI-Led Medical Devices Laggards of 1H Set to Gather Pace in 2H
2026-07-14 08:41:07
ISRG, IDXX and ALC are three AI-driven medical device laggards with strong business momentum and improving earnings estimates for a potential 2H rebound.
Alcon & RxSight Collaborate to Develop Adjustable PCIOL Technology
2026-07-13 10:40:46
ALC is developing adjustable presbyopia-correcting lenses that pair advanced optics with post-surgery light adjustment.
DELL & 3 More Stocks With Strong Interest Coverage to Buy Now
2026-07-13 09:56:52
DELL, Brinker International, Tapestry and Alcon pair strong interest coverage with solid growth prospects amid elevated borrowing costs.
RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook
2026-07-10 22:02:11
RxSight NASDAQ: RXST reported preliminary second-quarter financial results and provided updates on its product pipeline following a newly announced strategic collaboration agreement with Alcon, with management pointing to both near-term commercial headwinds and longer-term opportunities in adjustable intraocular lenses.
Wall Street Analysts Predict a 27.75% Upside in Alcon (ALC): Here's What You Should Know
2026-07-09 10:56:12
The mean of analysts' price targets for Alcon (ALC) points to a 27.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
ALC vs. IDXX: Which Stock Is the Better Value Option?
2026-07-07 12:41:10
Investors looking for stocks in the Medical - Instruments sector might want to consider either Alcon (ALC) or Idexx Laboratories (IDXX). But which of these two companies is the best option for those looking for undervalued stocks?
Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
2026-07-06 16:15:00
ALISO VIEJO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced a non-exclusive collaboration to jointly develop adjustable presbyopia-correcting intraocular lenses (PCIOLs).
Frequently Asked Questions
-
What is the current Alcon Inc. (ALC) stock price?
-
Alcon Inc.(NYSE:ALC) stock price is $68.48 in the last trading session. During the trading session, ALC stock reached the peak price of $92.55 while $61.835 was the lowest point it dropped to. The percentage change in ALC stock occurred in the recent session was 2.42% while the dollar amount for the price change in ALC stock was $1.62.
-
ALC's industry and sector of operation?
-
The NYSE listed ALC is part of Medical - Specialties industry that operates in the broader Healthcare sector.
-
Who are the executives of ALC?
-
Royce R. Bedward | Senior Vice President, General Counsel & Corporate Secretary
Kimberly Martin | Senior VP and Chief HR & Corporate Communications
Daniel Cravens | Vice President of Investor Relations
Leon Sergio Duplan Fraustro | Senior Vice President & President of Americas
Timothy C. Stonesifer | Senior Vice President & Chief Financial Officer -
How many employees does ALC have?
-
Number of ALC employees currently stands at 25628. ALC operates from Chemin de Blandonnet 8, Geneva, GE 1214, CH.
-
Link for ALC official website?
-
Official Website of ALC is: https://www.alcon.com
-
How do I contact ALC?
-
ALC could be contacted at phone #41 58 911 20 00 and can also be accessed through its website. ALC operates from Chemin de Blandonnet 8, Geneva, GE 1214, CH.
-
How many shares of ALC are traded daily?
-
The average number of ALC shares traded daily for last 3 months was 2.11M.
-
What is the market cap of ALC currently?
-
The market value of ALC currently stands at $33.4B with its latest stock price at $68.48